tiprankstipranks
AstraZeneca PLC (AZN)
NYSE:AZN
US Market
AZN
AstraZeneca
RESEARCH TOOLSreports

AstraZeneca (AZN) Drug Pipeline

370 Followers
Drug Name
Condition
Stage
Status
Study Name
Trial Start Date
Article
Azd5004
Healthy Participants
Phase I
Recruiting
A Study to Investigate the Pharmacokinetics of Different Formulations and Safety of AZD5004 in Healthy Participants Aged 18 to 55 Years
Mar 03, 2026
Saruparib, Azd4956
Solid Tumours
Phase I/II
Recruiting
Study of AZD4956 as Monotherapy and in Combination With Anti-Cancer Agents in Participants With Advanced/Metastatic Homologous Recombination Deficient Solid Tumours
Feb 26, 2026
Budesonide/Formoterol Fumarate Aerosphere, Budesonide/Formoterol Fumarate Pmdi
Asthma
Phase I
Recruiting
A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma
Feb 20, 2026
Benralizumab, Fasenra
Asthma, Hypereosinophilic Syndrome (Hes), Eosinophilic Granulomatosis With Polyangiitis (Egpa)
Phase III
Not Yet Recruiting
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
Feb 17, 2026
―
Azd0780
Healthy Participants
Phase I
Recruiting
A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics With AZD0780 Following Repeated Dose Administration in Healthy Adults With Elevated LDL-C Levels
Feb 13, 2026
[14C]Azd4144 Solution For Infusion, [14C]Azd4144 Oral Solution, Azd4144
Healthy Participants
Phase I
Active Not Recruiting
A Study of Absorption, Distribution, Metabolism and Excretion (ADME) of [14C]AZD4144
Feb 10, 2026
―
Zibotentan/Dapagliflozin Fdc
Healthy Participants
Phase I
Recruiting
A Study to Investigate the Concentrations of Zibotentan and Dapagliflozin in Blood When Given With and Without Food
Feb 05, 2026
Tremelimumab, Sc Durvalumab + Rhu, Iv Durvalumab, Medi4736
Solid Tumours
Phase I
Not Yet Recruiting
A Phase I Dose Escalation and Dose Expansion Study to Investigate the Pharmacokinetics and Safety of Subcutaneous Durvalumab
Jan 30, 2026
Dexamethasone, Pomalidomide, Bortezomib, Daratumumab, Carfilzomib, Azd0120
Relapsed Refractory Multiple Myeloma
Phase III
Recruiting
A Study Comparing AZD0120, a Dual-targeted CAR-T Against B-cell Maturation Antigen (BCMA) and CD19, Versus Standard Regimens in Participants With Relapsed Refractory Multiple Myeloma (DURGA-4)
Jan 30, 2026
Azd5335, Itraconazole
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal
Phase I
Recruiting
Drug-drug Interaction Study With AZD5335 and Itraconazole in Participants With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
Jan 23, 2026

FAQ

What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
    What is a clinical trial?
    A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
      What drugs does AstraZeneca PLC (AZN) have in its pipeline
      AZN is currently developing the following drugs: Azd5004, Saruparib, Azd4956, Budesonide/Formoterol Fumarate Aerosphere, Budesonide/Formoterol Fumarate Pmdi. These drug candidates are in various stages of clinical development as the company works toward FDA approval.